Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 226,160,423 papers from all fields of science
Search
Sign In
Create Free Account
immunotoxin HA22
Known as:
HA22
, MOXETUMOMAB PASUDOTOX
A recombinant immunotoxin consisting of the Fv portion of the anti-CD22 antibody covalently fused to a 38 KDa fragment of Pseudomonas exotoxin-A…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
10 relations
B-Lymphocytes
NCIt Antineoplastic Agent Terminology
Peptide Elongation Factor 2
Positive Regulation of Apoptosis
Expand
Broader (2)
Bacterial Toxins
Exotoxins
Narrower (1)
CAT-8015
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Phase I Study of the anti-CD22 immunotoxin moxetumomab pasudotox for childhood acute lymphoblastic leukemia.
A. Wayne
,
N. Shah
,
+9 authors
I. Pastan
Blood
2017
Corpus ID: 206951748
Novel therapies are needed to overcome chemotherapy resistance for children with relapsed/refractory acute lymphoblastic leukemia…
Expand
Review
2016
Review
2016
New monoclonal antibodies for the treatment of acute lymphoblastic leukemia.
N. Farhadfar
,
M. Litzow
Leukemia research : a Forum for Studies on…
2016
Corpus ID: 46846435
Review
2015
Review
2015
Immunoconjugates in the management of hairy cell leukemia.
R. Kreitman
,
I. Pastan
Baillière's Best Practice & Research: Clinical…
2015
Corpus ID: 13779013
2014
2014
Heterocyclic ring extension of androstenedione: Synthesis and cytotoxicity of fused pyran, pyrimidine and thiazole derivatives
R. Mohareb
,
N. S. Abbas
,
M. Abdelaziz
Steroids
2014
Corpus ID: 999971
2013
2013
Methylation of the DPH1 promoter causes immunotoxin resistance in acute lymphoblastic leukemia cell line KOPN-8.
Xiaobo Hu
,
Huiqin Wei
,
+4 authors
I. Pastan
Leukemia research : a Forum for Studies on…
2013
Corpus ID: 13762606
Review
2013
Review
2013
Hairy Cell Leukemia—New Genes, New Targets
R. Kreitman
Current Hematologic Malignancy Reports
2013
Corpus ID: 19338592
Hairy cell leukemia (HCL), a B cell malignancy comprising 2 % of all leukemias, has become quite exciting recently with regard to…
Expand
2009
2009
Androgen metabolism and biotransformation in nontumoral and malignant human liver tissues and cells
O. M. Granata
,
Letizia Cocciadifero
,
+5 authors
G. Carruba
Journal of Steroid Biochemistry and Molecular…
2009
Corpus ID: 21532162
Highly Cited
2007
Highly Cited
2007
Anti–Mesothelin Immunotoxin SS1P in Combination with Gemcitabine Results in Increased Activity against Mesothelin-Expressing Tumor Xenografts
R. Hassan
,
V. Broaddus
,
Shannon M. Wilson
,
D. Liewehr
,
Jingli Zhang
Clinical Cancer Research
2007
Corpus ID: 1890908
Purpose: To determine the antitumor activity of the anti–mesothelin immunotoxin SS1P in combination with gemcitabine against…
Expand
Highly Cited
2005
Highly Cited
2005
YC-1 [3-(5′-Hydroxymethyl-2′-furyl)-1-benzyl Indazole] Exhibits a Novel Antiproliferative Effect and Arrests the Cell Cycle in G0-G1 in Human Hepatocellular Carcinoma Cells
Shih-Wei Wang
,
S. Pan
,
+6 authors
C. Teng
Journal of Pharmacology and Experimental…
2005
Corpus ID: 12832915
This study delineates the antiproliferative activities and in vivo efficacy of YC-1 [3-(5′-hydroxymethyl-2′-furyl)-1-benzyl…
Expand
Highly Cited
2004
Highly Cited
2004
Induction of caspase-dependent programmed cell death in B-cell chronic lymphocytic leukemia by anti-CD22 immunotoxins.
T. Decker
,
M. Oelsner
,
+5 authors
T. Licht
Blood
2004
Corpus ID: 13882586
B cells of chronic lymphocytic leukemia (CLL) are long-lived in vivo, possibly because of defects in apoptosis. We investigated…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE